Return to homepagePandemic Pact

Clinical and immunovirological aspects of SARS-CoV2 infection in a cohort of pregnant women and newborns.

  • Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Total publications:0 publications

Grant number: COV20_00808

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)

  • Principal Investigator

    Maria Luisa Navarro Gómez

  • Research Location

    Spain

  • Lead Research Institution

    FUNDACION INVESTIGACION BIOMEDICA HOSPITAL GREGORIO MARAÑON

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)Newborns (birth to 1 month)

  • Vulnerable Population

    Pregnant women

  • Occupations of Interest

    Unspecified

Abstract

National prospective multicenter study carried out in RECLIP healthcare centers. At least 150 mother-newborn pairs with confirmed SARS-CoV2 infection during pregnancy will be analyzed. Epidemiological and clinical aspects, treatment of the infection, evolution will be collected. In 50 couples, microbiological studies of SARS-Cov-2 will be carried out in respiratory, blood, placenta, urine and feces of the newborn, breast milk, and immunological samples at the time of diagnosis of the pregnant woman and at birth in the newborn , and prospectively up to 6 months of life of the infant, aimed at knowing in depth the transmission of the infection as well as the immune response that occurs in these populations against SARS-CoV-2